CLINICAL EFFICACY OF BOSENTAN OF BABIES WITH CONGENITAL HEART DISEASE ASSOCIATED PULMONARY ARTERIAL HYPERTENSION

被引：0
|
作者：
Zhang, X. Z. [1 ]
Wang, Q. [2 ]
Zhang, S. J. [1 ]
Liu, S. [1 ]
Sun, J. J. [1 ]
Li, J. [1 ]
Ming, L. [1 ]
机构：
[1] Zhengzhou Univ, Dept Clin Lab, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Shihezi Univ, Sch Med, Shihezi, Xinjiang Uygur, Peoples R China
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2017年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
LY011
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Bosentan for Pulmonary Arterial Hypertension in Adults With Congenital Heart Disease
    Monfredi, Oliver
    Griffiths, Linda
    Clarke, Bernard
    Mahadevan, Vaikom S.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (10): : 1483 - 1488
  • [2] Effect of bosentan in children with pulmonary arterial hypertension associated with congenital heart disease
    Rosenzweig, E. Berman
    Ivy, D. D.
    Doran, A. K.
    Claussen, L. R.
    Yung, D.
    Widlitz, A. C.
    Abman, S.
    Barst, R. J.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 617 - 617
  • [3] EFFICACY AND SAFETY OF BOSENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION SECONDARY TO CONGENITAL HEART DISEASE
    Meng Lili
    Zhu Xianyang
    Zhang Duanzhen
    [J]. HEART, 2013, 99 : A42 - A42
  • [4] Clinical experience with bosentan for the treatment of pulmonary hypertension associated with congenital heart disease
    Carlsen, J.
    Humbert, M.
    Kiely, D. G.
    van Lierop, C.
    Schwierin, B.
    Hoeper, M. M.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 215 - 216
  • [5] Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects
    Sitbon, O.
    Beghetti, M.
    Petit, J.
    Iserin, L.
    Humbert, M.
    Gressin, V.
    Simonneau, G.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 25 - 31
  • [6] Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease
    Diller, Gerhard-Paul
    Dimopoulos, Konstantinos
    Kaya, Mehmet G.
    Harries, Carl
    Uebing, Anselm
    Li, Wei
    Koltsida, Evdokia
    Gibbs, J. Simon R.
    Gatzoulis, Michael A.
    [J]. HEART, 2007, 93 (08) : 974 - 976
  • [7] Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease
    Kotlyar, Eugene
    Sy, Raymond
    Keogh, Anne M.
    Kermeen, Fiona
    Macdonald, Peter S.
    Hayward, Christopher S.
    McNeil, Keith D.
    Celermajer, David S.
    [J]. CARDIOLOGY IN THE YOUNG, 2006, 16 (03) : 268 - 274
  • [8] Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease
    Benza, RL
    Rayburn, BK
    Tallaj, JA
    Coffey, CS
    Pinderski, LJ
    Parnoukian, SV
    Bourge, RC
    [J]. CHEST, 2006, 129 (04) : 1009 - 1015
  • [9] Pulmonary arterial hypertension treatment with bosentan in pediatric patients with congenital heart disease
    Romero Jimenez, Rosa M.
    Garcia Sanchez, Raquel
    Gimenez Manzorro, Alvaro
    Martinez Fernandez-Llamazares, Cecilia
    Sanjurjo Saez, Maria
    [J]. PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 347 - 347
  • [10] Macitentan superior to bosentan in pulmonary arterial hypertension due to congenital heart disease?
    Blok, I. M.
    Van Riel, A. C. M. J.
    Schuuring, M. J.
    De Bruin-Bon, R. H. A. C. M.
    Van Dijk, A. P. J.
    Zwinderman, A. H.
    Mulder, B. J. M.
    Bouma, B. J.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 458 - 458
12345